Tamara Iturriaga

Tamara Iturriaga

Auto-generated profile, based on publicly available information

Tamara Iturriaga

ESBIDA Research Group, Department of Sports Science, Faculty of Medicine, Health and Sports, Universidad Europea de Madrid, Madrid, Spain

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2024 in Scandinavian Journal of Medicine & Science in Sports
Verified
Journal Article
Open access
ASAlicia Sosa‐Pedreschi
Alicia Sosa‐Pedreschi
MDMarcio Vinicius Fagundes Donadio
Marcio Vinicius Fagundes Donadio
TITamara Iturriaga‐Ramírez
Tamara Iturriaga‐Ramírez
TYThomas Yvert
Thomas Yvert
FPFernanda Pérez‐Salazar
Fernanda Pérez‐Salazar
MRMargarita Perez Ruiz
Margarita Perez Ruiz
Introduction: Among the limited studies on physical exercise interventions in adults with cystic fibrosis (CF), few have specifically addressed the improvement of peripheral muscle strength and body fat‐free mass. The aim of this study was to examine the impacts of a remotely supervised, individualized 8‐week resistance training program of moderate to high intensity on strength and body composition in these subjects.Methods: This was a randomized controlled trial performed in adults with CF. The exercise group (EX) performed three 1‐h resistance training sessions per week over 8 weeks. The control group (CON) followed the physical activity recommendations of their physician. The main outcomes were muscle strength and body composition, with secondary measures including pulmonary function and quality of life. Two‐way repeated measures analysis was used.Results: In 23 participants (age 32.13 ± 7.72 years), the intervention showed a significant beneficial effect on leg press strength, with a large effect size, both in absolute (p = 0.011; = 0.281) and relative (p = 0.007; = 0.310) terms. Large intervention effects were observed on total fat mass (p < 0.001; = 0.415), body adiposity index (p < 0.001; = 0.436), and fat mass index (p < 0.001; = 0.445), all showing reduction in the EX group. In addition, significant large size effects were detected on total fat‐free mass (p = 0.046; = 0.177), trunk fat‐free mass (p = 0.039; = 0.188), and fat‐free mass index (p = 0.048; = 0.174), all favoring exercise. No significant effects were observed on pulmonary function and quality of life.Conclusions: An 8‐week remotely supervised resistance training program, with moderate to high intensity, effectively improved lower limb muscle strength and body composition.

6 September 2023 in Pediatric Pulmonology
Verified
Journal Article
Open access
MDMarcio Vinicius Fagundes Donadio
Marcio Vinicius Fagundes Donadio
Marta Amor-BarbosaMarta Amor-Barbosa
Marta Amor-Barbosa
FVFernanda Maria Vendrusculo
Fernanda Maria Vendrusculo
TRTamara Iturriaga Ramirez
Tamara Iturriaga Ramirez
ESElena Santana‐Sosa
Elena Santana‐Sosa
MRMargarita Perez Ruiz
Margarita Perez Ruiz
Introduction: Exercise intolerance is common in chronic airway diseases (CAD), but its mechanisms are still poorly understood. The aim of this study was to evaluate exercise capacity and its association with lung function, ventilatory limitation, and ventilatory efficiency in children and adolescents with cystic fibrosis (CF) and asthma when compared to healthy controls.Methods: Cross‐sectional study including patients with mild‐to‐moderate asthma, CF and healthy children and adolescents. Anthropometric data, lung function (spirometry) and exercise capacity (cardiopulmonary exercise testing) were evaluated. Primary outcomes were peak oxygen consumption (VO2peak), forced expiratory volume in 1 s (FEV1), breathing reserve (BR), ventilatory equivalent for oxygen consumption (VE/VO2) and for carbon dioxide production (VE/VCO2), both at the ventilatory threshold (VT1) and peak exercise.Results: Mean age of 147 patients included was 11.8 ± 3.0 years. There were differences between asthmatics and CF children when compared to their healthy peers for anthropometric and lung function measurements. Asthmatics showed lower VO2peak when compared to both healthy and CF subjects, although no differences were found between healthy and CF patients. A lower BR was found when CF patients were compared to both healthy and asthmatic. Both CF and asthmatic patients presented higher values for VE/VO2 and VE/VCO2 at VT1 when compared to healthy individuals. For both VE/VO2 and VE/VCO2 at peak exercise CF patients presented higher values when compared to their healthy peers.Conclusion: Patients with CF achieved good exercise capacity despite low ventilatory efficiency, low BR, and reduced lung function. However, asthmatics reported reduced cardiorespiratory capacity and normal ventilatory efficiency at peak exercise. These results demonstrate differences in the mechanisms of ventilatory limitation to maximum exercise testing in children and adolescents with CAD.

17 July 2025 in ERJ Open Research
Verified
Journal Article
Open access
FSFernanda Salazar-Pérez
Fernanda Salazar-Pérez
VSVerónica Sanz-Santiago
Verónica Sanz-Santiago
IMInés de Mir-Messa
Inés de Mir-Messa
OPOlaia Sardon Prado
Olaia Sardon Prado
EAErika Rezola Arcelus
Erika Rezola Arcelus
MDMarcio Vinicius Fagundes Donadio
Marcio Vinicius Fagundes Donadio
Background: Post-infectious bronchiolitis obliterans (PIBO) arises after lower respiratory tract infection during childhood and is marked by impaired lung function. Despite possible impacts on exercise capacity, cardiorespiratory fitness in PIBO patients remain largely unknown. This study aimed to examine cardiorespiratory fitness and identify possible demographic and clinical–functional associations. Methods: The following variables were examined in a multicentre, cross-sectional study conducted in clinically stable PIBO patients aged 6–20 years: cardiorespiratory fitness (exercise testing), lung function (spirometry and impulse oscillometry), muscle strength (handgrip, upper and lower extremities), functional capacity (30-s sit-to-stand (STS) test), physical activity level (physical activity questionnaire adolescents and children; PAQ-A-C), body mass index (BMI), quality of life (Saint George's respiratory questionnaire; SGRQ) and dyspnoea perception (modified Medical Research Council scale). Results: 51 patients were enrolled (mean age 13.2±4.2 years, 49% female). BMI z-score was 0.06±1.20. Lung function tests indicated moderate-to-severe obstruction (forced expiratory volume in 1 s (FEV 1 ) z-score −3.55±1.30) and elevated airway resistance (R5 Hz 165.8±53.64%). Peak oxygen consumption ( V′ O 2 peak ) was 36.8±8.58 mL·kg −1 ·min −1 (47% ≤10 percentile) and breathing reserve 7.08±8.29%, indicating ventilatory limitation. Handgrip strength was 0.49±0.14 kg·kg −1 . The 30-s STS test was 27.2±5.7 repetitions. PAQ-A/PAQ-C was 1.89±0.46 indicating a low physical activity level. SGRQ was 20.1±10.8%. There was no resting dyspnoea. Multivariate regression identified significant associations between V′ O 2 peak and FEV 1 (p<0.001), BMI (p<0.001), SGRQ (p=0.005), female sex (p=0.002) and age (p=0.033). Conclusions: In these patients, cardiorespiratory fitness was impaired mainly due to ventilatory limitations. Lung function, upper and lower limb muscle strength, BMI, quality of life, sex and age were all associated with fitness level.

1 January 2024 in Sao Paulo Medical Journal
Verified
Journal Article
Open access
PDF file
TITamara Iturriaga
Tamara Iturriaga
FSFernanda Salazar-Pérez
Fernanda Salazar-Pérez
MCMarta Casallo-Cerezo
Marta Casallo-Cerezo
Guillermo García-Pérez-de-SevillaGuillermo García-Pérez-de-Sevilla
Guillermo García-Pérez-de-Sevilla
ASAlicia Sosa-Pedreschi
Alicia Sosa-Pedreschi
MRMargarita Perez Ruiz
Margarita Perez Ruiz
Patients with severe coronavirus disease 2019 (COVID-19) often require hospital admission and experience sequelae such as chronic fatigue or low muscle mass.

5 December 2025 in European Journal of Applied Physiology
Verified
Journal Article
Open access
PDF file
ILIsabel María Sánchez Lorente
Isabel María Sánchez Lorente
TYThomas Yvert
Thomas Yvert
TITamara Iturriaga
Tamara Iturriaga
LSLara Sanchez-Barroso
Lara Sanchez-Barroso
Mar LarrosaMar Larrosa
Mar Larrosa
CDCatalina Santiago Dorrego
Catalina Santiago Dorrego
Background: Maximal oxygen uptake (VO 2max ) is the gold standard for assessing cardiopulmonary fitness. However, the link between VO 2max and mitochondrial function is complex, with no direct causality proven. Analysing mtDNA copy number offers an innovative way to understand aerobic performance by measuring mitochondrial biogenesis, although its relation to physical performance and fitness is not well studied, especially in trained individuals. Objective: This study aimed to compare VO 2max and mtDNA copy number in blood leukocytes between highly trained runners and nontrained men. It also examined how leukocyte mtDNA content adapts to a 6-week HIIT aerobic training programme in nontrained individuals. Methods: We conducted a cross-sectional study with 20 highly trained runners and 20 nontrained healthy subjects. Then, we implemented a 6-week HIIT training programme for the nontrained group, comparing their VO 2max and mtDNA copy number to a control group. Participants trained 4 min/4 min HIIT treadmill running, three times a week. Results: The cross-sectional part showed that highly trained runners had significantly higher mtDNA copy numbers than nontrained subjects ( p = 0.046; d = 0.652; 95% CI: [0.01, 1.28]; [medium–large effect]); further, we observed a significant positive correlation between mtDNA copy number and VO 2max combining both groups ( p = 0.013; R 2 = 0.153 [small–moderate effect]). After the 6-week HIIT programme, the intervention group showed significant increases in both VO 2max ( p < 0.001) and mtDNA copy number ( p = 0.015), with large and medium effect sizes, respectively. The intervention group’s mtDNA copy number increased by 321.6 ± 391.6%; 95% CI: [120.2, 522.9], compared to 12.8 ± 32.8%; 95% CI: [− 5.4, 30.9] in controls, indicating substantial interindividual variability, which could be attributed to a combination of biological factors, but we also observed indications of a potential responder versus non-responder pattern. Conclusion: These findings align with previous research, indicating that mtDNA copy number correlates with VO 2max , being higher in highly trained runners than in nontrained subjects, and increasing with training after a 6-week HIIT intervention. This study is novel in showing that a 6-week HIIT programme significantly boosts leukocyte mtDNA content, enhancing our understanding of individual adaptations to endurance training.

18 September 2025 in Current Protocols
Verified
Journal Article
Open access
Lisset Pantoja-ArévaloLisset Pantoja-Arévalo
Lisset Pantoja-Arévalo
TYThomas Yvert
Thomas Yvert
TITamara Iturriaga
Tamara Iturriaga
VSVerónica Sanz‐Santiago
Verónica Sanz‐Santiago
OBOlga Barceló
Olga Barceló
MRMargarita Perez Ruiz
Margarita Perez Ruiz
Muscle health has not been thoroughly analyzed in pediatric cystic fibrosis (CF) under elexacaftor/tezacaftor/ivacaftor (ETI) therapy together with exercise interventions in randomized controlled trials (RCTs). The aim of this study will be to determine the effects of a virtual live exercise training intervention on muscle health and cardiorespiratory fitness (CRF) variables in a pediatric population with CF under ETI therapy. The ‘FIQMODE’ Study (FIQ for CF in Spanish, or fibrosis quística; MOD for modulator therapy; and E for exercise) is a two‐arm RCT to evaluate the feasibility and efficacy of a novel exercise intervention to improve the muscle health and quality of life (QoL) of children and adolescents with CF under ETI pharmacological therapies. The exercise group will follow a 16‐week, supervised, strength‐oriented virtual live exercise training intervention. The control group will follow the standard World Health Organization recommendations for physical activity. Primary outcomes will be muscle health (lower and upper limb strength, respiratory muscle strength, lower limb functional mobility, anthropometry, and body composition) and CRF. Secondary outcomes will be clinical history, lung function, inflammatory status, lifestyle and QoL, adherence, and the Mediterranean Diet Quality Index. Participants will complete measures at baseline (pre‐intervention), 16 weeks post‐intervention, and 8 months follow‐up after the intervention. FIQMODE will provide an evidence‐informed protocol for exercise‐based therapy focused on outcomes reported in a robust RCT that can be applied across children and adolescents with CF under ETI therapy. FIQMODE will support the standardization of CF therapies with ETI together with exercise therapies, which will maximize the usability of exercise in medical applications, improve muscle quality, reduce pulmonary exacerbation, boost pharmacological improvement, and ultimately help improve the lifestyle of children and adolescents with CF.Trial registration: The protocol has been approved by the Ethics Committee of the Universidad Politécnica de Madrid (REF. 20231215) and registered on ClinicalTrials.gov (NCT06322446). This research was funded by the Instituto de Salud Carlos III, which is co‐funded by the European Regional Development Fund (PI 23/00299). The Instituto de Salud Carlos III supported this study through the project agreement “FIQMODE” with the Universidad Politécnica de Madrid (C2311600157). © 2025 The Author(s). Current Protocols published by Wiley Periodicals LLC.